Madison, N.J.- LEO Pharma Inc. today announced a donation of $25,000 to the New Jersey Pandemic Relief Fund (NJPRF) supporting resources to fight the medical, social, and economic impact of COVID-19 in communities across the state.
LEO Pharma Inc. is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in medical dermatology, based in Madison, N.J.
NJPRF provides grants to existing organizations “with a demonstrated track record of caring for vulnerable communities” with 100% of donations providing essential services to those in need and helping those on the front lines of the COVID-19 pandemic response, including the healthcare community. NJPRF is hosted by the Community Foundation of New Jersey.
“COVID-19 continues to take a significant toll on New Jersey families and neighborhoods, and we hope our donation can provide some relief to those who are most in need,“ said Christopher Posner, President and CEO, LEO Pharma Inc. “As the pandemic evolves affecting New Jersey and beyond, LEO Pharma Inc. remains committed to supporting our U.S. employees, serving healthcare providers and delivering medicines for people affected by skin conditions.”